Baiyu Pharmaceutical Established (Ginkgo Factory)

Innovative Drug Ginkgolide Injection Approved

Phase I Clinical Launch Of Ginkgolide Dropping Pills

Phase II Clinical Launch Of Ginkgolide Dropping Pills

Establishment Of Small Molecule Innovative Drug Research Center

Phase III Clinical Launch Of Ginkgolide Dropping Pills

1.1 Small Molecule BY1298 Chinese IND Application

The Freeze-dried Powder Injection Workshop Has Passed The EU GMP Certification

BY1298 Phase I Clinical Trial

BY1921 Obtained IND In The United States And IND In China

Freeze Dried Powder Injection Workshop Passed Brazilian GMP Certification

Baiyu Pharmaceutical Enters into Exclusive Licensing Agreement with Novartis for Investigational Anti-Tumor Small Molecule Drug

Ginkgo Total Lactone Dropping Pills Complete Phase III Clinical Trial

Ginkgo Lactone Injection Obtains Registration Certificate in Azerbaijan

Ginkgo Total Lactone Dropping Pills Complete Registration Inspection and On-Site GMP Inspection